CEVEC Pharmaceuticals GmbH

CEVEC Pharmaceuticals GmbH: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing

CEVEC’s license partner RZNOMICS Inc. receives approval to initiate clinical development of CAP® Ad Technology-produced gene therapy vector in liver cancer patients

CEVEC and UCB sign agreement for the use of CEVEC’s ELEVECTA(R) AAV manufacturing technology in Gene Therapy

CEVEC Pharmaceuticals GmbH: CEVEC closes growth financing round to serve strong demand in viral vector technologies for cell and gene therapies

CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies

CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA(R) in gene therapy